Ann: Annual Report to shareholders-NEU.AX, page-2

The annual report is out!

As far as I can tell there is, as you'd expect, no new information in the report.

They are still reporting the same timelines: FXS meeting in H1, Rett trial finished in Q4. TBI results in April. So (counting fingers and toes) that's sometime in the next two weeks, isn't it?

On the flip side, still no news about the concussion trial timelines (though as of 21 Jan clinicaltrials had been updated to say June 2016). This will be a question for the AGM.

When's the AGM? What a good question. Whenever it is I hope to be there.

One final comment: for an AGM report there's a lot of broad information about 2566, 2591, their mode of action and what potential diseases/ conditions they could be used for. This part of the annual report almost reads like an investor presentation! If you wanted to give a book/pdf to someone to explain why you were invested in the company it would fill that role nicely. I found it interesting that there was that sort of emphasis in the annual, more so than previous years I'm sure (though I'll have to go back and read and check).

Interested in other people's thoughts...